Actively Recruiting
Effect of TEAS on PONV After Spinal Surgery
Led by Jyoti Pandya · Updated on 2025-03-24
72
Participants Needed
1
Research Sites
437 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical acupoint stimulation (TEAS) compared to patients without TEAS.
CONDITIONS
Official Title
Effect of TEAS on PONV After Spinal Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male and female patients 18 years or older
- American Society of Anesthesiologists (ASA) classification I, II, or III
- Undergoing elective spinal surgery expected to last no more than four hours
- Capable and willing to provide consent
You will not qualify if you...
- Neuraxial (intrathecal or epidural) block
- Significant ongoing vestibular disease or dizziness
- Nausea or vomiting within 24 hours prior to surgery
- Use of antiemetic or emetogenic drugs within 3 days of surgery
- Documented alcohol or substance abuse within 3 months before surgery
- Limb abnormalities such as burn or amputation
- Poorly controlled diabetes mellitus (fasting plasma glucose >126 mg/dL or <70 mg/dL)
- Implantation of metal or electrical devices such as pacemakers, defibrillators, nerve stimulators, or internal hearing aids
- Rash, local infection, keloid, or any skin condition interfering with acupoint stimulation
- Clinically diagnosed major psychiatric conditions like bipolar disorder, uncontrolled major depression, or schizophrenia
- Chemotherapy or radiation therapy within 7 days before surgery
- Use of investigational products within 3 months before surgery
- Any condition deemed by the investigator to make participation unsafe (including unstable cardiovascular, pulmonary, renal, hepatic conditions, or seizures)
- Special populations such as prisoners, pregnant or lactating women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Ohio State University Wexner Medical Center
Columbus, Ohio, United States, 43210
Actively Recruiting
Research Team
J
Juan Fiorda, MD, PhD
CONTACT
A
Alberto Uribe, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here